Skip to content
10-Q

Quarterly Report

SHENGTAI PHARMACEUTICAL, INC.

0001144204-12-062072

← back to feed
Filed
Nov 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · Nov 13, 2012 9.58M sh
Capex Q1 2013 · Sep 30, 2012 $1.08K
Capex Q1 2013 · Sep 30, 2011 $1.08K
Operating Cash Flow Q1 2013 · Sep 30, 2012 $4.87M
Operating Cash Flow Q1 2013 · Sep 30, 2011 −$14.15M
Short Term Debt Q1 2013 · Sep 30, 2012 $75.54M
Short Term Debt Q1 2013 · Jun 30, 2012 $73.48M
Cash And Equivalents Q1 2013 · Sep 30, 2012 $9.49M
Cash And Equivalents Q1 2013 · Jun 30, 2012 $4.9M
Cash And Equivalents Q1 2013 · Sep 30, 2011 $3.62M
Cash And Equivalents Q1 2013 · Jun 30, 2011 $4.05M
Stockholders Equity Q1 2013 · Sep 30, 2012 $62.41M
Stockholders Equity Q1 2013 · Jun 30, 2012 $62.33M
Current Liabilities Q1 2013 · Sep 30, 2012 $106.83M
Current Liabilities Q1 2013 · Jun 30, 2012 $110.25M
Current Assets Q1 2013 · Sep 30, 2012 $70.62M
Current Assets Q1 2013 · Jun 30, 2012 $74.02M
Total Assets Q1 2013 · Sep 30, 2012 $169.24M
Total Assets Q1 2013 · Jun 30, 2012 $172.59M
Sga Expense Q1 2013 · Sep 30, 2012 $3.29M
Sga Expense Q1 2013 · Sep 30, 2011 $2.15M
Net Income Q1 2013 · Sep 30, 2012 $196.3K
Net Income Q1 2013 · Sep 30, 2011 $883.56K
Operating Income Q1 2013 · Sep 30, 2012 $1.77M
Operating Income Q1 2013 · Sep 30, 2011 $1.23M
Gross Profit Q1 2013 · Sep 30, 2012 $5.06M
Gross Profit Q1 2013 · Sep 30, 2011 $3.39M
Cost Of Revenue Q1 2013 · Sep 30, 2012 $43.69M
Cost Of Revenue Q1 2013 · Sep 30, 2011 $36.67M
Revenue Q1 2013 · Sep 30, 2012 $48.74M
Revenue Q1 2013 · Sep 30, 2011 $40.06M